However, recent evidence shows BLM mRNA to be overexpressed in a plethora of cancers including colon, breast, and hematological cancers when compared with the normal samples (Alzahrani et al., 2020). Here, BLM is linked to hematopoietic and lymphoid cell neoplasm.